Bromley Brings His No-Nonsense Style To Science Adviser's Job

WASHINGTON—The view with respect to Yale nuclear physicist D. Allan Bromley seems to be unanimous: The new assistant to the pres- ident for science and technology, in the words of one colleague, “cuts through the crap to get things done.” On April 20, the White House issued an announcement that the science community had been anxiously awaiting for months: President Bush had selected his new science adviser. Long rumored for the position, Bromley comes to the job with true

Written byJeffrey Mervis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—The view with respect to Yale nuclear physicist D. Allan Bromley seems to be unanimous: The new assistant to the pres- ident for science and technology, in the words of one colleague, “cuts through the crap to get things done.”

On April 20, the White House issued an announcement that the science community had been anxiously awaiting for months: President Bush had selected his new science adviser.

Long rumored for the position, Bromley comes to the job with true-blue Republican credentials: As an eight-year member of the moribund White House Science Council and arecentappointee to the National Science Board, he already holds two presidentially appointed spots. Now, the 63-year-old Bromley will actually be wearing two hats in the Bush administration: assistant to the president and director of the Office of Science and Technology Policy (OSTP). Each job has its strengths and pitfalls. As presidential assistant, Bromley holds a rank one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies